Category Archives: Cardiovascular

Study design and setting This was a population-based cohort study using health administrative databases in Ontario, the most populous province of Canada. Permanent residents of Ontario receive physician and hospital services through the publicly-funded Ontario Health Insurance Plan (OHIP). Study population We included permanent residents aged ≥ 20 years with incident non-gestational diabetes diagnosed between January 1, […]

Apolipoprotein (apo) B measurement is a recommended alternative to low-density lipoprotein cholesterol (LDL-C) The 2021 Canadian Cardiovascular Society guideline on dyslipidemia recommends that physicians may use levels of either non-high-density lipoprotein cholesterol (HDL-C) or apo B instead of LDL-C for screening and targets of treatment.1 Non-HDL-C represents total cholesterol minus cholesterol from HDL particles; apo […]

Ultra-processed food significantly raises the risk of high blood pressure, heart disease, heart attacks and strokes, according to two studies that one expert says should serve as a wake-up call for governments worldwide. Global consumption of heavily processed items such as cereals, protein bars, fizzy drinks, ready meals and fast food has soared in recent […]

The old adage that “laughter is the best medicine” may contain an element of truth when it comes to heart health. A study has demonstrated that having a chuckle causes the tissue inside the heart to expand – and increases oxygen flow around the body. Patients with coronary artery disease who engaged in a course […]

Specialty

Julian Gillmore, MBBS, MD, PhDCredit: American Heart Association The 30-month results of the phase 3 ATTRibute-CM trial provide the latest insight into the effects of acoramidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM) ahead of a potential regulatory submission for the agent. Presented during a hot line session at the European Society of Cardiology (ESC) […]

Specialty

A new analysis of the DELIVER trial indicated hospitalization as a first presentation of worsening heart failure in patients with heart failure with mildly reduced or preserved ejection fraction was significantly associated with subsequent mortality. Presented at the European Society of Cardiology Congress 2023, results from the secondary analysis of the DELIVER trial showed oral […]